Digital Neuro Biomarkers Market Growth In 2026: Market Size, Key Drivers And Future Outlook
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Digital Neuro Biomarkers Market Growth Potential: How Will Market Size Shift Through 2030?
The digital neuro biomarkers market has seen rapid expansion lately. It is forecast to expand from $0.95 billion in 2025 to $1.22 billion in 2026, achieving a compound annual growth rate (CAGR) of 27.5%. Historically, this expansion has been driven by factors such as the increasing occurrence of neurological conditions, a greater uptake of wearable technologies, enhanced attention on cognitive evaluation, improvements in neuroimaging techniques, and initial studies in digital biomarker creation.
The digital neuro biomarkers market size is poised for rapid expansion over the coming years. This market is projected to reach $3.19 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 27.2%. The anticipated growth during this period can be attributed to factors such as the increasing incorporation of artificial intelligence in neurological diagnostics, a rising need for remote patient monitoring, the enlargement of tele-neurology services, escalating investments in neuroscience research, and the creation of tailored neurology treatment approaches. Key developments expected in the forecast timeframe include a broader application of cloud-based neurological data analytics, the implementation of real-time brain monitoring technologies, an increase in mobile cognitive assessment applications, the incorporation of machine learning into biomarker analysis, and the proliferation of predictive and precision neurology platforms.
Get A Free Sample Report With In-Depth Market Insights:
Digital Neuro Biomarkers Market Growth Momentum: What Factors Are Shaping Demand?
The expanding emphasis on the timely identification and ongoing observation of neurological conditions is projected to boost the expansion of the digital neuro biomarkers market. This process utilizes digital tools like wearable technology, mobile apps, and sensor-based systems to continually evaluate neurological function, cognitive abilities, and behavioral patterns, facilitating the prompt recognition of neurological conditions. This sharpened attention is driven by public health campaigns and clinical objectives focused on detecting cognitive decline and neurodegenerative illnesses before advanced symptoms manifest. Digital neuro biomarkers aid these endeavors by providing objective, live data, assisting clinicians and researchers in identifying minor neurological shifts and implementing early treatments. For example, the U.S. Centres for Disease Control and Prevention’s Healthy Brain Initiative reported in 2024 that approximately one billion people worldwide are impacted by neurological disorders, with roughly 50 million suffering from epilepsy and 24 million from Alzheimer’s disease. Consequently, the heightened emphasis on early detection and continuous monitoring of neurological disorders via digital solutions is stimulating the growth of the digital neuro biomarkers market.
Digital Neuro Biomarkers Market Segments: Where Is Growth Concentrated?
The digital neuro biomarkers market covered in this report is segmented –
1) By Type: Wearable, Mobile-Based Applications, Sensors, Other Types
2) By Deployment Mode: Cloud-Based Platforms, On-Premise Platforms, Hybrid Deployment Models
3) By Biomarker Type: Cognitive Digital Biomarkers, Motor Function Digital Biomarkers, Speech And Language Digital Biomarkers, Behavioral Digital Biomarkers
4) By End-User: Healthcare Companies, Healthcare Providers, Payers, Other End-Users
Subsegments:
1) By Wearable: Smart Wristbands, Smart Headbands, Smart Watches, Smart Clothing, Implantable Devices
2) By Mobile-Based Applications: Cognitive Assessment Applications, Neurological Monitoring Applications, Mental Health Tracking Applications, Motor Function Assessment Applications, Speech And Language Tracking Applications
3) By Sensors: Electroencephalography Sensors, Electrocardiography Sensors, Eye Tracking Sensors, Motion Tracking Sensors, Biometric Monitoring Sensors
4) By Other Types: Cloud Based Platforms, Data Analytics Tools, Digital Therapeutic Platforms, Artificial Intelligence Enabled Assessment Tools, Virtual Reality Based Assessment Tools
Digital Neuro Biomarkers Market Trends Redefining Industry Growth
Leading companies in the digital neuro biomarkers market are concentrating on developing accessible research infrastructures, such as WearGait PD, to support the creation, validation, and regulatory assessment of wearable-based digital neuro biomarkers for neurological disorders. WearGait PD represents a regulatory science dataset that offers synchronized wearable sensor and gait information from individuals with Parkinson’s disease and age-matched controls, enabling the extraction and evaluation of gait-derived digital biomarkers for monitoring disease and assessing its progression. For example, in July 2024, the U.S. Food and Drug Administration (FDA), a U.S.-based regulatory agency, released “WearGait PD: Wearables Dataset for Gait in Parkinson’s Disease and Age-Matched Controls,” an open-access dataset intended to assist researchers and industry developers in deriving and validating digital biomarkers. This dataset comprises raw inertial measurement unit (IMU) acceleration and rotational velocity data, insole pressure recordings, and synchronized gait annotations, which collectively facilitate algorithm testing, metric validation, and the development of wearable sensor-based monitoring tools.
Digital Neuro Biomarkers Market Industry Leaders And Competitive Landscape
Major companies operating in the digital neuro biomarkers market are F. Hoffmann-La Roche AG, Merck KGaA, Biogen Inc., Evidation Health Inc., Huma Therapeutics Limited, Altoida Inc, Cogstate Limited, Quibim S.L., Empatica Inc., Linus Health Inc., Cambridge Cognition Holdings plc, Brainomix Limited, Mindstrong Health Inc., Neurotrack Technologies Inc., Feel Therapeutics Inc., BrainCheck Inc., IXICO plc, NeuraMetrix Inc., NeuraLight Ltd., Koneksa Health Inc., Sonde Health Inc., Aural Analytics Inc., Winterlight Labs Inc.
View The Full Digital Neuro Biomarkers Market Report:
Digital Neuro Biomarkers Market Regional Analysis And Leading Geography
North America was the largest region in the digital neuro biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital neuro biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
